{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:17:55Z","timestamp":1790119075129,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.jcv.2007.11.012","type":"journal-article","created":{"date-parts":[[2008,3,7]],"date-time":"2008-03-07T00:17:59Z","timestamp":1204849079000},"page":"52-57","source":"Crossref","is-referenced-by-count":40,"title":["Human respiratory syncytial virus and other viral infections in infants receiving palivizumab"],"prefix":"10.1016","volume":"42","author":[{"given":"Guy","family":"Boivin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Caouette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line","family":"Frenette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Carbonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manale","family":"Ouakki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaston","family":"De Serres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2007.11.012_bib1","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/JVI.63.7.2941-2950.1989","article-title":"Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function","volume":"63","author":"Beeler","year":"1989","journal-title":"J Virol"},{"key":"10.1016\/j.jcv.2007.11.012_bib2","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3201\/eid0906.030017","article-title":"Human metapneumovirus infections in hospitalized children","volume":"9","author":"Boivin","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jcv.2007.11.012_bib3","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1086\/423213","article-title":"Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutants","volume":"190","author":"DeVincenzo","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2007.11.012_bib4","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1067\/S0022-3476(03)00454-2","article-title":"Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease","volume":"143","author":"Feltes","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcv.2007.11.012_bib5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00063198-200205000-00011","article-title":"Respiratory syncytial virus infection: clinical features, management, and prophylaxis","volume":"8","author":"Greenough","year":"2002","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jcv.2007.11.012_bib6","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1086\/431981","article-title":"Human metapneumovirus infection in adults with community-acquired pneumonia and exacerbation of chronic obstructive pulmonary disease","volume":"41","author":"Hamelin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcv.2007.11.012_bib7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants","volume":"102","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcv.2007.11.012_bib8","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(02)11391-2","article-title":"Metapneumovirus and acute wheezing in children","volume":"360","author":"Jartti","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2007.11.012_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1086\/314846","article-title":"A direct comparison of the activities of two humanized respiratory syncytial virus monoclonal antibodies: MEDI-493 and RSHZl9","volume":"180","author":"Johnson","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2007.11.012_bib10","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1086\/514115","article-title":"Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus","volume":"176","author":"Johnson","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2007.11.012_bib11","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/01.inf.0000053884.21238.13","article-title":"Selected populations at increased risk from respiratory syncytial virus infection","volume":"22","author":"Meissner","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jcv.2007.11.012_bib12","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1128\/AAC.49.11.4700-4707.2005","article-title":"Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency","volume":"49","author":"Mejias","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jcv.2007.11.012_bib13","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/S1526-0542(04)90023-1","article-title":"Respiratory syncytial virus: the virus, the disease and the immune response","volume":"5","author":"Ogra","year":"2004","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcv.2007.11.012_bib14","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1016\/S0264-410X(03)00355-4","article-title":"Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies","volume":"21","author":"Piedra","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2007.11.012_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jcv.2007.11.012_bib16","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1097\/01.inf.0000053880.92496.db","article-title":"Respiratory syncytial virus and other respiratory viruses","volume":"22","author":"Welliver","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jcv.2007.11.012_bib17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa025472","article-title":"Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children","volume":"350","author":"Williams","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcv.2007.11.012_bib18","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1086\/425515","article-title":"Variable resistance to palivizumab in cotton rats by respiratory syncytial virus mutants","volume":"190","author":"Zhao","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2007.11.012_bib19","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.virol.2003.10.018","article-title":"Respiratory syncytial virus escape mutant derived in vitro resists palivizumab prophylaxis in cotton rats","volume":"318","author":"Zhao","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.jcv.2007.11.012_bib20","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1128\/JVI.79.7.3962-3968.2005","article-title":"In vivo selection of respiratory syncytial viruses resistant to palivizumab","volume":"79","author":"Zhao","year":"2005","journal-title":"J Virol"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653207004325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653207004325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T18:33:51Z","timestamp":1588444431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653207004325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S1386653207004325"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2007.11.012","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}